Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryuji Yamaguchi

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Cell|April 8, 2003
A role for Ran-GTP and Crm1 in blocking re-replicationRyuji Yamaguchi, John Newport
Biochimica Et Biophysica Acta|February 28, 2009
Dynamics of mitochondrial structure during apoptosis and the enigma of Opa1Ryuji Yamaguchi, Guy Perkins
Cancer Research|November 5, 2011
Finding a Panacea among combination cancer therapiesRyuji Yamaguchi, Guy Perkins
Advances in Experimental Medicine and Biology|February 8, 2020
An Emerging Model for Cancer Development from a Tumor Microenvironment Perspective in Mice and HumansRyuji Yamaguchi, Guy Perkins
Odontology|September 20, 2005
Clinical evaluation of a new bleaching product "Polanight" in a Japanese populationShuichi Tsubura, Ryuji Yamaguchi
Cancer Biology & Therapy|May 4, 2018
Animal models for studying tumor microenvironment (TME) and resistance to lymphocytic infiltrationRyuji Yamaguchi, Guy Perkins
Journal of Nutritional Science and Vitaminology|November 25, 2015
Food Safety Program in Asian CountriesRyuji Yamaguchi, Lucy Sun Hwang
Pharmacology & Therapeutics|October 23, 2018
Targeting Mcl-1 and other Bcl-2 family member proteins in cancer therapyRyuji Yamaguchi, Lydia Lartigue, Guy Perkins
FEBS Letters|November 27, 2015
Targeting cholesterol with β-cyclodextrin sensitizes cancer cells for apoptosisRyuji Yamaguchi, Guy Perkins, Kiichi Hirota
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|July 28, 2016
VHL-deficient renal cancer cells gain resistance to mitochondria-activating apoptosis inducers by activating AKT through the IGF1R-PI3K pathwayRyuji Yamaguchi, Hiroshi Harada, Kiichi Hirota
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Cell|April 8, 2003
A role for Ran-GTP and Crm1 in blocking re-replicationRyuji Yamaguchi, John Newport
Biochimica Et Biophysica Acta|February 28, 2009
Dynamics of mitochondrial structure during apoptosis and the enigma of Opa1Ryuji Yamaguchi, Guy Perkins
Cancer Research|November 5, 2011
Finding a Panacea among combination cancer therapiesRyuji Yamaguchi, Guy Perkins
Advances in Experimental Medicine and Biology|February 8, 2020
An Emerging Model for Cancer Development from a Tumor Microenvironment Perspective in Mice and HumansRyuji Yamaguchi, Guy Perkins
Odontology|September 20, 2005
Clinical evaluation of a new bleaching product "Polanight" in a Japanese populationShuichi Tsubura, Ryuji Yamaguchi
Cancer Biology & Therapy|May 4, 2018
Animal models for studying tumor microenvironment (TME) and resistance to lymphocytic infiltrationRyuji Yamaguchi, Guy Perkins
Journal of Nutritional Science and Vitaminology|November 25, 2015
Food Safety Program in Asian CountriesRyuji Yamaguchi, Lucy Sun Hwang
Pharmacology & Therapeutics|October 23, 2018
Targeting Mcl-1 and other Bcl-2 family member proteins in cancer therapyRyuji Yamaguchi, Lydia Lartigue, Guy Perkins
FEBS Letters|November 27, 2015
Targeting cholesterol with β-cyclodextrin sensitizes cancer cells for apoptosisRyuji Yamaguchi, Guy Perkins, Kiichi Hirota
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|July 28, 2016
VHL-deficient renal cancer cells gain resistance to mitochondria-activating apoptosis inducers by activating AKT through the IGF1R-PI3K pathwayRyuji Yamaguchi, Hiroshi Harada, Kiichi Hirota
Pageof 2